Mary Larijani, MD
Appointments and Referrals: 1-800-TRY-CHOP (1-800-879-2467)
Skip to content
MD - Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, PA
Internal Medicine - Lankenau Medical Center, Wynnewood, PA
Dermatology - Thomas Jefferson University, Philadelphia, PA
Dermatology - Drexel University College of Medicine/Hahnemann University Hospital, Philadelphia, PA
Dermatology - The Children’s Hospital of Philadelphia, Philadelphia, PA
Dermatology – American Board of Dermatology
Tamazian S, Oboite M, Larijani M, Oliver B, Milbar H, Jen M, Treat JR.: Toxic erythema of chemotherapy affecting the ears of an infant: A case report. Pediatr Dermatol 38: 512-513, Mar 2021.
Mary Larijani MD, Adam I. Rubin MD, Melinda Jen MD: Recurrent blisters in a 6-year-old girl. Pediatric Dermatology 38(3), May/June 2021.
Nadhan KS, Larijani M, Abbott J, Doyle AM, Linfante AW, Chung CL.: Prevalence and Types of Genital Lesions in Organ Transplant Recipients. JAMA Dermatol 154: 323-329, Mar 2018. PMCID: PMC5885815
Neidig L, Jin A, Larijani M, Chung CL.: Penile basal cell carcinoma in a black kidney transplant recipient. JAAD Case Rep 4: 969-971, Oct 2018. PMCID: PMC6214887
Kemp DM, Pidich A, Larijani M, Jonas R, Lash E, Sato T, Terai M, De Pizzol M, Allegretti M, Igoucheva O, Alexeev V.: Ladarixin, a dual CXCR1/2 inhibitor, attenuates experimental melanomas harboring different molecular defects by affecting malignant cells and tumor microenvironment. Oncotarget 8: 14428-14442, Feb 2017. PMCID: PMC5362416
Igoucheva, O, Grazzini, M, Pidich, A, Kemp, D M, Larijani, M, Farber, M, Lorton, J, Rodeck, U, Alexeev, V: Immunotargeting and eradication of orthotopic melanoma using a chemokine-enhanced DNA vaccine. Gene Ther 20: 939-48, Sep 2013.
Le S, Finn JP, Larijani ME, Marino MJ, Schaffhauser H.: Detection of low level histamine H3 receptor occupancy by autoradiography. J Neurosci Methods 185: 70-5, Dec 2009.
Griffin Jr. TD, Larijani M, Hazan E, Saedi N.: Anatomy of Facial Vasculature/Musculature. Reconstructive Dermatologic Surgery. Shang I Brian Jiang (eds.). Jaypee Brothers Medical Publishers Ltd. 2018.
Larijani M. Erythema Elevatum Diutinum: Not your average leukocytoclastic vasculitis. Oral presentation: Philadelphia Dermatological Society. Philadelphia, PA. October 2018.
Larijani M. "Erythema Elevatum Diutinum: Not your average leukocytoclastic vasculitis.", Philadelphia Dermatological Society, Philadelphia, PA. October 2018.
Larijani M. "Racial Differences in Rates of Malignant and Infectious Cutaneous Genital Disease After Solid Organ Transplantation." American Transplant Congress. Seattle, WA. June 2018.
2020, Top Doctor, Main Line Today
2016, Stelwagon Competition First Prize Winner, Section on Dermatology of The College of Physicians of Philadelphia
2015, Magna Cum Laude, Sidney Kimmel Medical College of Thomas Jefferson University
2014, Alpha Omega Alpha Honor Medical Society, Junior Induction, Pennsylvania Alpha Chapter
2014, Third Place in Poster Competition, AOA Research Symposium, Sidney Kimmel Medical College at Thomas Jefferson University
2013, American Skin Association’s Medical Student Grant
2013, Hobart Amory Hare Honor Society, Sidney Kimmel Medical College at Thomas Jefferson University
2012, Lavine Scholarship, Thomas Jefferson University
2012, American Dermatological Association Medical Student Fellowship
2011, Graduated with Honors, University of Michigan
2016-present, American Academy of Dermatology
2016-present, Society for Pediatric Dermatology
2016-present, Women's Dermatologic Society
The Patient Experience Rating is an average of all responses to the care provider related questions shown above from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
We are committed to true transparency. However, to ensure the comments are fair and correctly attributed, we review each one before posting to the website. We exclude entire comments that disclose patient's protected health information, are off-topic, or include other confidential or inappropriate content. Comments will appear on provider bios only if providers have a minimum number of comments.
Comments are shared internally for education purposes to ensure that we are doing our very best for the patients and families for whom we are privileged to care.
The comments are submitted by patients and families and reflect their views and opinions. The comments are not endorsed by and do not reflect the views of Children’s Hospital of Philadelphia.